Leveraging the synergies of Cerbios Chemical and Biological Divisions to create a unique integrated service for ADC Drug Substance production.
As a natural evolution of established competence in Monoclonal Antibodies (mAbs) as well as in the Highly Potent Active Ingredient's(HPAIs) process development and cGMP manufacturing, Cerbios recently expanded its activities in the Antibody Drug Conjugates (ADC) area.
Taking advantage of its state-of-the-art infrastructure to manufacture and handle the different components of ADCs (mAbs and payload), Cerbios can offer the unique opportunity of a single entry point for ADC drug substance manufacturing.
Multidisciplinary project teams gathering expertise both in the biologic and HPAI areas is an extraordinary opportunity for Cerbios to execute a straightforward approach to ADC, considering all the different elements arising from biological and chemical perspectives.
Cerbios has the internal capacity to manufacture any single component of the ADC, along with the conjugation process. In addition it has the flexibility to handle the conjugation between payload and mAbs from third party manufacturers.
Collaboration with companies specialized in Fill and Finish of these particular categories of HPAI can also speedup the development phase for our partners and reduce the risk of integrated service failure